#United States #Boston #Lundbeck #Innovation Hub

Lundbeck Sets Foot in Greater Boston for Innovation

In a significant strategic shift, H. Lundbeck A/S has announced its decision to move its US headquarters from Deerfield, Illinois, to the vibrant ecosystem of Greater Boston, Massachusetts. This move signifies Lundbeck's determination to establish a global innovation hub, capitalizing on Greater Boston's reputation as a leading center for life sciences, which will significantly enhance Lundbeck’s access to science, talent, and industry partnerships.

The relocation, expected to unfold over the next year, aligns with Lundbeck's proactive investment strategy in the US, a crucial market for the company. The transition not only aims to strengthen its operational framework but also to ensure seamless service continuity for its clients while retaining the exceptional talent within its team.

Strengthening the Neuroscience Portfolio

Lundbeck's President and CEO, Charl van Zyl, articulated that the US has been instrumental in driving Lundbeck’s commercial progress, and will remain central to its ambitious future growth plans. With a focus on scaling opportunities created through its advancing portfolio and pipeline, Lundbeck's commitment to neuroscience innovation is unwavering. The emergence of AI and digital capabilities will further enhance their strategies.

A Hub of Collaboration

The new Greater Boston hub will serve as a catalyst for collaboration and partnerships between Lundbeck's existing expertise and the thriving external innovation landscape. Tarek Samad, Lundbeck's Executive Vice President and Head of Research and Development, emphasized that having their research and development expertise at the heart of one of the world’s most dynamic life sciences ecosystems will unveil extensive new opportunities for collaboration, ultimately leading to innovative treatments.

With renowned academic and healthcare institutions in close proximity, along with a wealth of biotechnology firms and top-tier scientific talent, Lundbeck's new location is poised to energize its developmental efforts. The region’s stronghold in artificial intelligence and digital technologies is expected to further bolster Lundbeck’s innovation capabilities.

Committed to Exceptional Performance

As Lundbeck embarks on this transformative journey, Thomas Gibbs, Executive Vice President and President of Lundbeck US, highlighted the core of their strength – the talent and culture their team instills each day. The newly established hub aims to unite their teams and capabilities effectively, ensuring they can continue to advance their neuroscience portfolio and enhance their service to patients and partners alike.

As the transition progresses, Lundbeck is committed to maintaining the integrity of its existing operations in Deerfield, simultaneously ensuring that the valuable expertise and personnel that have driven the company’s success remain intact. This strategic move not only affirms Lundbeck's position in the market but sets a robust foundation for future endeavors aimed at expanding their impact on brain health globally.

Ultimately, Lundbeck's relocation to Greater Boston is more than just a change in address; it's a bold step towards reinforcing its mission to provide innovative treatments for those affected by brain diseases. By embedding itself within a leading life sciences network, Lundbeck continues its trail of excellence in neuroscience innovation, paving the way for breakthroughs that could make a significant difference in the lives of patients worldwide.

For more information about Lundbeck and its commitment to neuroscience, visit their corporate site at www.lundbeck.com.